/PRNewswire/ Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies today announced that Dana-Farber Cancer Institute.
Today, the Multiple Myeloma Research Foundation (MMRF) announced that new insights related to novel targets, risk assessment, and precision medicine approaches generated through the use of the MMRF landmark CoMMpass Study will be presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. In total, ASH will feature 33 presentations developed through the work of more than 200 researchers from 180 institutions all using the CoMMpass data. - Click here if this is your press release! - eTurboNews | Trends | Travel News
/PRNewswire/ Today, the Multiple Myeloma Research Foundation (MMRF) announced that new insights related to novel targets, risk assessment, and precision.
/PRNewswire/ Today, the Multiple Myeloma Research Foundation (MMRF) announced that new insights related to novel targets, risk assessment, and precision.
Data from MMRF Landmark CoMMpass Study Validated as Unparalleled in Cancer Research at 63rd American Society of Hematology (ASH) Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.